Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Experimental characterisation of a proton kernel model for pencil beam scanning techniques.

De Marzi L, Da Fonseca A, Moignier C, Patriarca A, Goudjil F, Mazal A, Buvat I, Hérault J.

Phys Med. 2019 Aug;64:195-203. doi: 10.1016/j.ejmp.2019.07.013. Epub 2019 Jul 23.

PMID:
31515020
2.

Spatial fractionation of the dose in proton therapy: Proton minibeam radiation therapy.

De Marzi L, Nauraye C, Lansonneur P, Pouzoulet F, Patriarca A, Schneider T, Guardiola C, Mammar H, Dendale R, Prezado Y.

Cancer Radiother. 2019 Sep 4. pii: S1278-3218(19)30306-3. doi: 10.1016/j.canrad.2019.08.001. [Epub ahead of print]

PMID:
31494038
3.

The Indenoisoquinoline TOP1 Inhibitors Selectively Target Homologous Recombination-Deficient and Schlafen 11-Positive Cancer Cells and Synergize with Olaparib.

Marzi L, Szabova L, Gordon M, Weaver Ohler Z, Sharan SK, Beshiri ML, Etemadi M, Murai J, Kelly K, Pommier Y.

Clin Cancer Res. 2019 Aug 13. doi: 10.1158/1078-0432.CCR-19-0419. [Epub ahead of print]

PMID:
31409613
4.

Simulation and experimental validation of a prototype electron beam linear accelerator for preclinical studies.

Lansonneur P, Favaudon V, Heinrich S, Fouillade C, Verrelle P, De Marzi L.

Phys Med. 2019 Apr;60:50-57. doi: 10.1016/j.ejmp.2019.03.016. Epub 2019 Mar 27.

PMID:
31000086
5.

Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma.

Todesca P, Marzi L, Critelli RM, Cuffari B, Caporali C, Turco L, Pinelli G, Schepis F, Carulli L, de Maria N, Casari F, Scaglioni R, Villa E.

Hepatology. 2019 Aug;70(2):745-747. doi: 10.1002/hep.30588. Epub 2019 Apr 11. No abstract available.

PMID:
30802985
6.

Impact of a Multidisciplinary Team on Alcohol Recidivism and Survival After Liver Transplant for Alcoholic Disease.

Magistri P, Marzi L, Guerzoni S, Vandelli M, Mereu F, Ascari F, Guidetti C, Tarantino G, Serra V, Guerrini GP, Ballarin R, Moscara M, De Maria N, Villa E, Di Benedetto F.

Transplant Proc. 2019 Jan - Feb;51(1):187-189. doi: 10.1016/j.transproceed.2018.02.212. Epub 2018 Jun 30.

PMID:
30736972
7.

Tumor Control in RG2 Glioma-Bearing Rats: A Comparison Between Proton Minibeam Therapy and Standard Proton Therapy.

Prezado Y, Jouvion G, Guardiola C, Gonzalez W, Juchaux M, Bergs J, Nauraye C, Labiod D, De Marzi L, Pouzoulet F, Patriarca A, Dendale R.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):266-271. doi: 10.1016/j.ijrobp.2019.01.080. Epub 2019 Jan 29.

PMID:
30703513
8.

Implementation of planar proton minibeam radiation therapy using a pencil beam scanning system: A proof of concept study.

De Marzi L, Patriarca A, Nauraye C, Hierso E, Dendale R, Guardiola C, Prezado Y.

Med Phys. 2018 Nov;45(11):5305-5316. doi: 10.1002/mp.13209. Epub 2018 Oct 12.

PMID:
30311639
9.

Proton radiography with a commercial range telescope detector using dedicated post processing methods.

Krah N, De Marzi L, Patriarca A, Pittá G, Rinaldi I.

Phys Med Biol. 2018 Oct 17;63(20):205016. doi: 10.1088/1361-6560/aae043.

PMID:
30203783
10.

Clinical outcomes with long-term sorafenib treatment of patients with hepatocellular carcinoma: a multicenter real-life study.

Sacco R, Granito A, Bargellini I, Zolfino T, Saitta C, Marzi L, Tapete G, Bresci G, Marinelli S, Tovoli F, Attardo S, Rossi M, Urbani L, Marchi S, Buccianti P, Cabibbo G.

Future Oncol. 2018 Dec;14(29):3049-3058. doi: 10.2217/fon-2018-0281. Epub 2018 Aug 9.

PMID:
30091371
11.

Experimental Set-up for FLASH Proton Irradiation of Small Animals Using a Clinical System.

Patriarca A, Fouillade C, Auger M, Martin F, Pouzoulet F, Nauraye C, Heinrich S, Favaudon V, Meyroneinc S, Dendale R, Mazal A, Poortmans P, Verrelle P, De Marzi L.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):619-626. doi: 10.1016/j.ijrobp.2018.06.403. Epub 2018 Jul 11.

PMID:
30017793
12.

Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors.

Marzi L, Agama K, Murai J, Difilippantonio S, James A, Peer CJ, Figg WD, Beck D, Elsayed MSA, Cushman M, Pommier Y.

Mol Cancer Ther. 2018 Aug;17(8):1694-1704. doi: 10.1158/1535-7163.MCT-18-0028. Epub 2018 May 10.

13.

High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma.

Persico M, Aglitti A, Aghemo A, Rendina M, Lleo A, Ciancio A, Di Marco V, Lampertico P, Brunetto MR, Zuin M, Andreone P, Villa E, Troshina G, Calvaruso V, Degasperi E, Coco B, Giorgini A, Conti F, Di Leo A, Marzi L, Boccaccio V, Bollani S, Maisonneuve P, Bruno S.

Aliment Pharmacol Ther. 2018 Jun;47(12):1705-1712. doi: 10.1111/apt.14685. Epub 2018 May 3.

PMID:
29722439
14.

Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals.

Faillaci F, Marzi L, Critelli R, Milosa F, Schepis F, Turola E, Andreani S, Vandelli G, Bernabucci V, Lei B, D'Ambrosio F, Bristot L, Cavalletto L, Chemello L, Sighinolfi P, Manni P, Maiorana A, Caporali C, Bianchini M, Marsico M, Turco L, de Maria N, Del Buono M, Todesca P, di Lena L, Romagnoli D, Magistri P, di Benedetto F, Bruno S, Taliani G, Giannelli G, Martinez-Chantar ML, Villa E.

Hepatology. 2018 Sep;68(3):1010-1024. doi: 10.1002/hep.29911.

15.

Proton beam therapy for skull base chordomas in 106 patients: A dose adaptive radiation protocol.

Fung V, Calugaru V, Bolle S, Mammar H, Alapetite C, Maingon P, De Marzi L, Froelich S, Habrand JL, Dendale R, Noël G, Feuvret L.

Radiother Oncol. 2018 Aug;128(2):198-202. doi: 10.1016/j.radonc.2017.12.017. Epub 2018 Jan 6.

PMID:
29310903
16.

Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study.

Critelli R, Milosa F, Faillaci F, Condello R, Turola E, Marzi L, Lei B, Dituri F, Andreani S, Sighinolfi P, Manni P, Maiorana A, Caporali C, di Benedetto F, Del Buono M, De Maria N, Schepis F, Martinez-Chantar ML, Giannelli G, Villa E.

Cell Death Dis. 2017 Aug 24;8(8):e3017. doi: 10.1038/cddis.2017.395.

17.

Prognostic signatures from hepatocellular carcinoma biopsy.

Marzi L, Villa E.

Hepat Oncol. 2017 Jul;4(3):65-68. doi: 10.2217/hep-2017-0016. Epub 2017 Oct 30. No abstract available.

18.

Development of a synthetic single crystal diamond dosimeter for dose measurement of clinical proton beams.

Moignier C, Tromson D, de Marzi L, Marsolat F, García Hernández JC, Agelou M, Pomorski M, Woo R, Bourbotte JM, Moignau F, Lazaro D, Mazal A.

Phys Med Biol. 2017 Jul 7;62(13):5417-5439. doi: 10.1088/1361-6560/aa70cf. Epub 2017 Jun 12.

PMID:
28604370
19.

BactDNA as an Independent Risk Factor for Short-Term Crohn's Disease Recurrence.

Sartini A, Verga MC, Marzi L, De Maria N, Villa E.

Am J Gastroenterol. 2016 Oct;111(10):1500-1501. doi: 10.1038/ajg.2016.333. No abstract available.

PMID:
27694860
20.

FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.

Marzi L, Combes E, Vié N, Ayrolles-Torro A, Tosi D, Desigaud D, Perez-Gracia E, Larbouret C, Montagut C, Iglesias M, Jarlier M, Denis V, Linares LK, Lam EW, Martineau P, Del Rio M, Gongora C.

Br J Cancer. 2016 Nov 8;115(10):1223-1233. doi: 10.1038/bjc.2016.313. Epub 2016 Sep 29.

21.

Mechanisms of phosphene generation in ocular proton therapy as related to space radiation exposure.

Chuard D, Anthonipillai V, Dendale R, Nauraye C, Khan E, Mabit C, De Marzi L, Narici L.

Life Sci Space Res (Amst). 2016 Aug;10:23-8. doi: 10.1016/j.lssr.2016.06.002. Epub 2016 Jul 7.

PMID:
27662784
22.

Dosimetric characteristics of four PTW microDiamond detectors in high-energy proton beams.

Marsolat F, De Marzi L, Patriarca A, Nauraye C, Moignier C, Pomorski M, Moignau F, Heinrich S, Tromson D, Mazal A.

Phys Med Biol. 2016 Sep 7;61(17):6413-29. doi: 10.1088/0031-9155/61/17/6413. Epub 2016 Aug 8.

PMID:
27499356
23.

Reprint of "Chordoma in children: Case-report and review of literature".

Habrand JL, Datchary J, Bolle S, Beaudré A, de Marzi L, Beccaria K, Stefan D, Grill J, Dendale R.

Rep Pract Oncol Radiother. 2016 Jul-Aug;21(4):412-7. doi: 10.1016/j.rpor.2016.04.003. Epub 2016 Apr 18. Review.

24.

Influence of beam incidence and irradiation parameters on stray neutron doses to healthy organs of pediatric patients treated for an intracranial tumor with passive scattering proton therapy.

Bonfrate A, Farah J, De Marzi L, Delacroix S, Hérault J, Sayah R, Lee C, Bolch WE, Clairand I.

Phys Med. 2016 Apr;32(4):590-9. doi: 10.1016/j.ejmp.2016.03.009. Epub 2016 Apr 2.

PMID:
27050170
25.

Chordoma in children: Case-report and review of literature.

Habrand JL, Datchary J, Bolle S, Beaudré A, de Marzi L, Beccaria K, Stefan D, Grill J, Dendale R.

Rep Pract Oncol Radiother. 2016 Jan-Feb;21(1):1-7. doi: 10.1016/j.rpor.2015.10.007. Epub 2015 Dec 8. Review.

26.

Efficacy and Safety of Adjuvant Proton Therapy Combined With Surgery for Chondrosarcoma of the Skull Base: A Retrospective, Population-Based Study.

Feuvret L, Bracci S, Calugaru V, Bolle S, Mammar H, De Marzi L, Bresson D, Habrand JL, Mazeron JJ, Dendale R, Noël G.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):312-21. doi: 10.1016/j.ijrobp.2015.12.016. Epub 2015 Dec 17.

PMID:
26883563
27.

Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection.

Sartini A, Bianchini M, Schepis F, Marzi L, De Maria N, Villa E.

Clin Case Rep. 2016 Jan 2;4(2):195-202. doi: 10.1002/ccr3.464. eCollection 2016 Feb.

28.

An empirical model for calculation of the collimator contamination dose in therapeutic proton beams.

Vidal M, De Marzi L, Szymanowski H, Guinement L, Nauraye C, Hierso E, Freud N, Ferrand R, François P, Sarrut D.

Phys Med Biol. 2016 Feb 21;61(4):1532-45. doi: 10.1088/0031-9155/61/4/1532. Epub 2016 Jan 27.

PMID:
26816191
29.

The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2.

Cabibbo G, Reig M, Gadaleta-Caldarola G, Galati G, Lombardi G, Mazza G, Marzi L, Saitta C, Nault JC, Sacco R.

Future Oncol. 2016 Feb;12(3):285-8. doi: 10.2217/fon.15.324. Epub 2016 Jan 18.

PMID:
26776157
30.

The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1.

Cabibbo G, Reig M, Gadaleta-Caldarola G, Galati G, Lombardi G, Mazza G, Marzi L, Saitta C, Nault JC, Sacco R.

Future Oncol. 2016 Feb;12(3):281-4. doi: 10.2217/fon.15.323. Epub 2016 Jan 18.

PMID:
26775918
31.

Analytical linear energy transfer model including secondary particles: calculations along the central axis of the proton pencil beam.

Marsolat F, De Marzi L, Pouzoulet F, Mazal A.

Phys Med Biol. 2016 Jan 21;61(2):740-57. doi: 10.1088/0031-9155/61/2/740. Epub 2016 Jan 6.

PMID:
26732530
32.

Configuration and validation of an analytical model predicting secondary neutron radiation in proton therapy using Monte Carlo simulations and experimental measurements.

Farah J, Bonfrate A, De Marzi L, De Oliveira A, Delacroix S, Martinetti F, Trompier F, Clairand I.

Phys Med. 2015 May;31(3):248-56. doi: 10.1016/j.ejmp.2015.01.017. Epub 2015 Feb 12.

PMID:
25682475
33.

Use of gEUD for predicting ear and pituitary gland damage following proton and photon radiation therapy.

De Marzi L, Feuvret L, Boulé T, Habrand JL, Martin F, Calugaru V, Fournier-Bidoz N, Ferrand R, Mazal A.

Br J Radiol. 2015 Apr;88(1048):20140413. doi: 10.1259/bjr.20140413. Epub 2015 Feb 11.

34.

Involvement of the Artemis protein in the relative biological efficiency observed with the 76-MeV proton beam used at the Institut Curie Proton Therapy Center in Orsay.

Calugaru V, Nauraye C, Cordelières FP, Biard D, De Marzi L, Hall J, Favaudon V, Mégnin-Chanet F.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):36-43. doi: 10.1016/j.ijrobp.2014.05.018. Erratum in: Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):457.

PMID:
25195988
35.

In vivo inflammatory effects of ceria nanoparticles on CD-1 mouse: evaluation by hematological, histological, and TEM analysis.

Poma A, Ragnelli AM, de Lapuente J, Ramos D, Borras M, Aimola P, Di Gioacchino M, Santucci S, De Marzi L.

J Immunol Res. 2014;2014:361419. doi: 10.1155/2014/361419. Epub 2014 Jun 17.

36.

Flake size-dependent cyto and genotoxic evaluation of graphene oxide on in vitro A549, CaCo2 and vero cell lines.

De Marzi L, Ottaviano L, Perrozzi F, Nardone M, Santucci S, De Lapuente J, Borras M, Treossi E, Palermo V, Poma A.

J Biol Regul Homeost Agents. 2014 Apr-Jun;28(2):281-9.

PMID:
25001660
37.

Monte Carlo modeling of proton therapy installations: a global experimental method to validate secondary neutron dose calculations.

Farah J, Martinetti F, Sayah R, Lacoste V, Donadille L, Trompier F, Nauraye C, De Marzi L, Vabre I, Delacroix S, Hérault J, Clairand I.

Phys Med Biol. 2014 Jun 7;59(11):2747-65. doi: 10.1088/0031-9155/59/11/2747. Epub 2014 May 6.

PMID:
24800943
38.

Letter: TNFα blockers and psoriasis: a 'reasonable paradox' - the role of TH-17 cells.

Sartini A, Di Girolamo M, Scarcelli A, Bertani A, Marzi L, Lasagni C, Merighi A, Villa E.

Aliment Pharmacol Ther. 2014 May;39(10):1244-6. doi: 10.1111/apt.12705. No abstract available.

39.

Secondary neutron doses received by paediatric patients during intracranial proton therapy treatments.

Sayah R, Farah J, Donadille L, Hérault J, Delacroix S, De Marzi L, De Oliveira A, Vabre I, Stichelbaut F, Lee C, Bolch WE, Clairand I.

J Radiol Prot. 2014 Jun;34(2):279-96. doi: 10.1088/0952-4746/34/2/279. Epub 2014 Apr 4.

PMID:
24704989
40.

Calibration of CT Hounsfield units for proton therapy treatment planning: use of kilovoltage and megavoltage images and comparison of parameterized methods.

De Marzi L, Lesven C, Ferrand R, Sage J, Boulé T, Mazal A.

Phys Med Biol. 2013 Jun 21;58(12):4255-76. doi: 10.1088/0031-9155/58/12/4255. Epub 2013 May 29.

PMID:
23719506
41.

Cytotoxicity and genotoxicity of ceria nanoparticles on different cell lines in vitro.

De Marzi L, Monaco A, De Lapuente J, Ramos D, Borras M, Di Gioacchino M, Santucci S, Poma A.

Int J Mol Sci. 2013 Feb 1;14(2):3065-77. doi: 10.3390/ijms14023065.

42.

[Localized Ewing sarcoma of the spine: a preliminary dose-escalation study comparing innovative radiation techniques in a single patient].

Vogin G, Biston MC, Marchesi V, Amessis M, De Marzi L, Lacroix F, Leroy A, Gassa F, Zefkili S, Helfre S.

Cancer Radiother. 2013 Feb;17(1):26-33. doi: 10.1016/j.canrad.2012.11.006. Epub 2013 Jan 18. French.

PMID:
23333459
43.

Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.

Festi D, Schiumerini R, Marzi L, Di Biase AR, Mandolesi D, Montrone L, Scaioli E, Bonato G, Marchesini-Reggiani G, Colecchia A.

Aliment Pharmacol Ther. 2013 Feb;37(4):392-400. doi: 10.1111/apt.12186. Epub 2012 Dec 20. Review.

44.

MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy.

Paillas S, Causse A, Marzi L, de Medina P, Poirot M, Denis V, Vezzio-Vie N, Espert L, Arzouk H, Coquelle A, Martineau P, Del Rio M, Pattingre S, Gongora C.

Autophagy. 2012 Jul 1;8(7):1098-112. doi: 10.4161/auto.20268. Epub 2012 May 31.

45.

Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.

Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A, Casazza G, Schiumerini R, Turco L, Di Biase AR, Mazzella G, Marzi L, Arena U, Pinzani M, Festi D.

Gastroenterology. 2012 Sep;143(3):646-654. doi: 10.1053/j.gastro.2012.05.035. Epub 2012 May 27.

PMID:
22643348
46.

Morphological transformation induced by multiwall carbon nanotubes on Balb/3T3 cell model as an in vitro end point of carcinogenic potential.

Ponti J, Broggi F, Mariani V, De Marzi L, Colognato R, Marmorato P, Gioria S, Gilliland D, Pascual Garcìa C, Meschini S, Stringaro A, Molinari A, Rauscher H, Rossi F.

Nanotoxicology. 2013 Mar;7(2):221-33. doi: 10.3109/17435390.2011.652681. Epub 2012 Jan 27.

PMID:
22279961
47.

Gut microbiota and its pathophysiology in disease paradigms.

Festi D, Schiumerini R, Birtolo C, Marzi L, Montrone L, Scaioli E, Di Biase AR, Colecchia A.

Dig Dis. 2011;29(6):518-24. doi: 10.1159/000332975. Epub 2011 Dec 12. Review.

PMID:
22179206
48.

Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma.

Paillas S, Boissière F, Bibeau F, Denouel A, Mollevi C, Causse A, Denis V, Vezzio-Vié N, Marzi L, Cortijo C, Ait-Arsa I, Askari N, Pourquier P, Martineau P, Del Rio M, Gongora C.

Cancer Res. 2011 Feb 1;71(3):1041-9. doi: 10.1158/0008-5472.CAN-10-2726. Epub 2010 Dec 15.

49.

[Proton beam therapy in pediatric radiotherapy].

Habrand JL, Bolle S, Datchary J, Alapetite C, Petras S, Helfre S, Feuvret L, Calugaru V, De Marzi L, Bouyon-Monteau A, Dendale R, Kalifa C, Grill J, Doz F.

Cancer Radiother. 2009 Oct;13(6-7):550-5. doi: 10.1016/j.canrad.2009.07.001. Epub 2009 Aug 18. French.

PMID:
19692282
50.

The PGD2 pathway, independently of FGF9, amplifies SOX9 activity in Sertoli cells during male sexual differentiation.

Moniot B, Declosmenil F, Barrionuevo F, Scherer G, Aritake K, Malki S, Marzi L, Cohen-Solal A, Georg I, Klattig J, Englert C, Kim Y, Capel B, Eguchi N, Urade Y, Boizet-Bonhoure B, Poulat F.

Development. 2009 Jun;136(11):1813-21. doi: 10.1242/dev.032631.

Supplemental Content

Support Center